RPS6KB1 and cancer: In addition to inhibiting mTOR and the downstream effectors of the mTOR pathway (4E-BP1 and S6K), Torin2 inhibited the phosphorylation of AKT, an important signaling (PI3K/AKT/mTOR)-pathway in ATC and a variety of cancers [24].